Sabra Health Care REIT, Inc.
NASDAQSabra Health Care REIT heads into the week with a split signal: short sellers are quietly reducing exposure while Raymond James reinstates coverage with an Underperform rating, putting the Street's caution on record just as the stock slips 10% over the past month to $18.56. The positioning picture is less alarming than the headline short interest implies. At nearly 12% of the free…
SBRA cost to borrow doubled to 0.50% in one week, up from 0.25%, signaling tightening short availability despite high overall lending capacity at 283% availability.
Snapshot as of 24 Jun 2026
Sabra Health Care REIT heads into the week with a split signal: short sellers are quietly reducing exposure while Raymond James reinstates coverage with an Underperform rating, putting the Street's caution on record…
Sabra Health Care REIT heads into the back half of May with short sellers quietly pressing harder — and the Street, despite nudging targets higher, staying firmly on the fence. Short interest has been building steadily…
Sabra Health Care REIT enters its April 30 earnings print with one of the more meaningful short positions in the healthcare REIT space, while options traders have recently turned more cautious than usual — a…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SBRA — free to start on ORTEX.
Sign up for free →Open SBRA on ORTEX